| Record Information | 
|---|
| Version | 5.0 | 
|---|
| Status | Detected but not Quantified | 
|---|
| Creation Date | 2021-09-11 23:37:49 UTC | 
|---|
| Update Date | 2021-09-26 23:18:03 UTC | 
|---|
| HMDB ID | HMDB0260107 | 
|---|
| Secondary Accession Numbers | None | 
|---|
| Metabolite Identification | 
|---|
| Common Name | (1S,4S,9R,10S,13R,14R)-5,5,9,14-Tetramethyltetracyclo[11.2.1.01,10.04,9]hexadec-6-ene | 
|---|
| Description | (1S,4S,9R,10S,13R,14R)-5,5,9,14-Tetramethyltetracyclo[11.2.1.01,10.04,9]hexadec-6-ene belongs to the class of organic compounds known as kaurane diterpenoids. These are diterpene alkaloids with a structure that is based on the kaurane skeleton. Kaurane is a tetracyclic compound that arises by cyclisation of a pimarane precursor followed by rearrangement. It possesses a [3,2,1]-bicyclic ring system with C15-C16 bridge connected to C13, forming the five-membered ring D. Based on a literature review very few articles have been published on (1S,4S,9R,10S,13R,14R)-5,5,9,14-Tetramethyltetracyclo[11.2.1.01,10.04,9]hexadec-6-ene. This compound has been identified in human blood as reported by (PMID: 31557052  ). (1s,4s,9r,10s,13r,14r)-5,5,9,14-tetramethyltetracyclo[11.2.1.01,10.04,9]hexadec-6-ene is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (1S,4S,9R,10S,13R,14R)-5,5,9,14-Tetramethyltetracyclo[11.2.1.01,10.04,9]hexadec-6-ene is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. | 
|---|
| Structure | CC1CC23CC1CCC2C1(C)CC=CC(C)(C)C1CC3 InChI=1S/C20H32/c1-14-12-20-11-8-16-18(2,3)9-5-10-19(16,4)17(20)7-6-15(14)13-20/h5,9,14-17H,6-8,10-13H2,1-4H3  | 
|---|
| Synonyms | Not Available | 
|---|
| Chemical Formula | C20H32 | 
|---|
| Average Molecular Weight | 272.476 | 
|---|
| Monoisotopic Molecular Weight | 272.25040103 | 
|---|
| IUPAC Name | 5,5,9,14-tetramethyltetracyclo[11.2.1.0^{1,10}.0^{4,9}]hexadec-6-ene | 
|---|
| Traditional Name | 5,5,9,14-tetramethyltetracyclo[11.2.1.0^{1,10}.0^{4,9}]hexadec-6-ene | 
|---|
| CAS Registry Number | Not Available | 
|---|
| SMILES | CC1CC23CC1CCC2C1(C)CC=CC(C)(C)C1CC3  | 
|---|
| InChI Identifier | InChI=1S/C20H32/c1-14-12-20-11-8-16-18(2,3)9-5-10-19(16,4)17(20)7-6-15(14)13-20/h5,9,14-17H,6-8,10-13H2,1-4H3  | 
|---|
| InChI Key | AJMOAIFBRXSMBT-UHFFFAOYSA-N | 
|---|
| Chemical Taxonomy | 
|---|
| Description |  Belongs to the class of organic compounds known as kaurane diterpenoids. These are diterpene alkaloids with a structure that is based on the kaurane skeleton. Kaurane is a tetracyclic compound that arises by cyclisation of a pimarane precursor followed by rearrangement. It possesses a [3,2,1]-bicyclic ring system with C15-C16 bridge connected to C13, forming the five-membered ring D. | 
|---|
| Kingdom | Organic compounds   | 
|---|
| Super Class | Lipids and lipid-like molecules   | 
|---|
| Class | Prenol lipids   | 
|---|
| Sub Class | Diterpenoids   | 
|---|
| Direct Parent | Kaurane diterpenoids   | 
|---|
| Alternative Parents |  | 
|---|
| Substituents | - Kaurane diterpenoid
 
- Polycyclic hydrocarbon
 
- Cyclic olefin
 
- Unsaturated aliphatic hydrocarbon
 
- Unsaturated hydrocarbon
 
- Olefin
 
- Hydrocarbon
 
- Aliphatic homopolycyclic compound
 
  | 
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds | 
|---|
| External Descriptors | Not Available | 
|---|
| Ontology | 
|---|
| Physiological effect | Not Available | 
|---|
| Disposition |  | 
|---|
| Process | Not Available | 
|---|
| Role | Not Available | 
|---|
| Physical Properties | 
|---|
| State | Not Available | 
|---|
| Experimental Molecular Properties | | Property | Value | Reference | 
|---|
 | Melting Point | Not Available | Not Available |  | Boiling Point | Not Available | Not Available |  | Water Solubility | Not Available | Not Available |  | LogP | Not Available | Not Available |  
  | 
|---|
| Experimental Chromatographic Properties | Not Available | 
|---|
| Predicted Molecular Properties |  | 
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference | 
|---|
 | Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022.  | 6.92 minutes | 32390414   |  | Predicted by Siyang on May 30, 2022 | 23.9798 minutes | 33406817   |  | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.56 minutes | 32390414   |  | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2909.4 seconds | 40023050   |  | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 803.7 seconds | 40023050   |  | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 290.7 seconds | 40023050   |  | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 419.9 seconds | 40023050   |  | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 697.8 seconds | 40023050   |  | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 957.2 seconds | 40023050   |  | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 995.9 seconds | 40023050   |  | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 94.1 seconds | 40023050   |  | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1946.1 seconds | 40023050   |  | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 633.7 seconds | 40023050   |  | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1802.0 seconds | 40023050   |  | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 727.5 seconds | 40023050   |  | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 615.8 seconds | 40023050   |  | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 526.2 seconds | 40023050   |  | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 694.7 seconds | 40023050   |  | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.2 seconds | 40023050   |  
 Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference | 
|---|
 | (1S,4S,9R,10S,13R,14R)-5,5,9,14-Tetramethyltetracyclo[11.2.1.01,10.04,9]hexadec-6-ene | CC1CC23CC1CCC2C1(C)CC=CC(C)(C)C1CC3 | 2423.4 | Standard polar | 33892256   |  | (1S,4S,9R,10S,13R,14R)-5,5,9,14-Tetramethyltetracyclo[11.2.1.01,10.04,9]hexadec-6-ene | CC1CC23CC1CCC2C1(C)CC=CC(C)(C)C1CC3 | 1997.3 | Standard non polar | 33892256   |  | (1S,4S,9R,10S,13R,14R)-5,5,9,14-Tetramethyltetracyclo[11.2.1.01,10.04,9]hexadec-6-ene | CC1CC23CC1CCC2C1(C)CC=CC(C)(C)C1CC3 | 2023.3 | Semi standard non polar | 33892256   |  
  | 
|---|
 | GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View | 
|---|
 | Predicted GC-MS | Predicted GC-MS Spectrum - (1S,4S,9R,10S,13R,14R)-5,5,9,14-Tetramethyltetracyclo[11.2.1.01,10.04,9]hexadec-6-ene GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4l-0690000000-5bd41317e0cda2822535 | 2021-09-24 | Wishart Lab | View Spectrum |  | Predicted GC-MS | Predicted GC-MS Spectrum - (1S,4S,9R,10S,13R,14R)-5,5,9,14-Tetramethyltetracyclo[11.2.1.01,10.04,9]hexadec-6-ene GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |  
  | 
|---|